Cullinan Therapeutics, Inc.
$21.70
-0.90 (-3.98%)
Price as of Aug 28, 2026 market close
Performance
- 1 Month
- +23.9%
- 3 Months
- +32.0%
- YTD
- +109.7%
- 1 Year
- +173.6%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 79.8%
- Largest decline max drawdown, since Aug 2025
- -29.8%
- Risk-adjusted return Sharpe ratio, 1-year
- 1.64
Own CGEM?
See how CGEM contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.